Black Diamond Therapeutics - 53 Year Dividend History | BDTX
Historical dividend payout and yield for Black Diamond Therapeutics (BDTX) since 1971. The current TTM dividend payout for Black Diamond Therapeutics (BDTX) as of November 29, 2024 is $0.00. The current dividend yield for Black Diamond Therapeutics as of November 29, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.150B |
$0.000B |
|
Black Diamond Therapeutics Inc. is an oncology medicine company. It engages in discovery and development of small molecule, tumor-agnostic therapies. The company's lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor and tyrosine-protein kinase. Black Diamond Therapeutics Inc. is based in Cambridge, Massachusetts.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
